ISAAAC firma un acuerdo estratégico con FIDETIA y el profesor Alberto Olmo de la Universidad de Sevilla.

El acuerdo con el Prof. Alberto Olmo (miembro fundador de ISAAAC) se formaliza a través de la Fundación FIDETIA, en las siguientes áreas:

– Actividades de valorización del dispositivo para la monitorización de un paciente con insuficiencia cardíaca, protegido por la patente P202131041 (CI22-00287)

– USECHIP: Cátedra de Microelectrónica de la Universidad de Sevilla (TSI-069100-2023-001 – Investigador).

Optimization of Differentiation Processes in Stem and Tumor Cells Based on Electrostimulation (PID2021-122529OB-I00 – Research Team)

Prof. Alberto Olmo

– Real-time prognostic value for volume monitoring using bioimpedance measurements in patients with acute heart failure (HEART-FAIL VOLUM) (DTS19/00134 – Researcher)

Measurement and electrostimulation system for cell differentiation and motility applications (P18-FR-2308 – Research Team)

– Real-time monitoring of hemodynamic variables with smart stents (IStent) using capacitive sensors and bioimpedance (RTI2018-093512-B-C21 – Research Team)

– Modeling and implementation of the freeze-casting technique: porosity gradients with tribomechanical

equilibrium and electrostimulated cell behavior (US-1259771 – Research Team)

– Integrated Microsystems for Cell Culture Experimentation (TEC2013-46242-C3-1-P – Working Team (Advanced/Departed))

– Development of a portable biomedical device for heart failure (P038-22/E16 – Researcher)

– Clinical trial of the new portable HFvolum device for real-time volume monitoring in patients with heart failure (PRECLI-HF) (AT 21_00010 – Research Team)

Specific agreements will be formalized according to the projects selected by Professor Alberto Olmo.

es_ES